Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 3, 2008, Pages 363-370

  Bielawski, Krzysztof ^a   Bielawska, Anna ^a   Popławska, Bozena ^a   Bołkun Skórnicka, Urszula ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Breast cancer; Cisplatin; Cytotoxicity; Dinuclear platinum complexes; DNA binding

Indexed keywords

3 PICOLINE; CISPLATIN; DIMINAZENE ACETURATE; DNA TOPOISOMERASE INHIBITOR; ETHIDIUM; ISOPROPYLAMINE; PICOLINE; PICOLINE DERIVATIVE; PLATINUM DERIVATIVE; PROPYLAMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BASE PAIRING; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CYTOTOXICITY; DNA SYNTHESIS; DRUG DNA BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50;

AMINES; ANIMALS; ANTINEOPLASTIC AGENTS; BASE PAIRING; BREAST NEOPLASMS; CATTLE; CELL LINE, TUMOR; CISPLATIN; DIMINAZENE; DNA; DNA TOPOISOMERASES, TYPE II; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; ETHIDIUM; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; ORGANOPLATINUM COMPOUNDS; THYMIDINE;

EID: 45849106478     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rosenberg B.: in: Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, Lippert B. Ed., p. 3, Wiley-VCH, Basel 1999.
2. Wong E., Giandomenico C.M.: Chem. Rev. 99, 2451 (1999).
3. Wheate N.J., Collins J.G.: Curr. Med. Chem. Anti-Cancer Agents 5, 267 (2005).
4. Farrell N.: Met. Ions Biol. Syst. 42, 251 (2004).
5. Liu Q., Qu Y., Van Antwerpen R., Farrell N.: Biochemistry 45, 4248 (2006).
6. Wheate N.J., Collins J.: Coord. Chem. Rev. 24, 133 (2003).
7. Mukhopadhyay R., Dubey P., Sarkar S.: J. Struct. Biol. 150, 277 (2005).
8. Denny W.A.: Curr. Med. Chem. 8, 533 (2001).
9. Bartulewicz D., Bielawski K., Bielawska A., Różański A.: Eur. J. Med. Chem. 36, 461 (2001).
10. Cozzi P.: Farmaco 58, 213 (2003).
11. Barcelo F., Ortiz-Lombardia M., Portugal J.: Biochim. Biophys. Acta 1519, 175 (2001).
12. Nguyen B., Hamelberg D., Bailly Ch., Colson P., Stanek J., Brun R., Neidle S., Wilson W.D.: Biophys. J. 86, 1028 (2004).
13. Portugal J.: FEBS Lett. 344, 136 (1994).
14. A. R. Morgan A.R., Lee J.S., Pulleyblank D.F., Murray N.L., Evans D.H.: Nucleic Acids Res. 7, 547 (1979).
15. Debart F., Periguad C., Gosselin D. et al.: J. Med. Chem. 32, 1074 (1989).
16. Carmichael J., Degraff W., Gazdar A., Minna J., Mitchell J.: Cancer Res. 47, 936 (1987).
17. Gonzalez V.M., Amo-Ochoa P., Perez J.M., Fuertes M.A., Masaguer J.R., Navarro-Ranninger C., Alonso C.: J. Inorg. Biochem. 63, 57 (1996).
18. Khan S.R.A., Guzman-Jimenez I., Whitmire K.H., Khokhar A.R.: Polyhedron 19, 975 (2000).
19. Prokop R., Kasparkova J., Novakova O., Marini V., Pizarro A.M., Navarro-Ranninger C., Brabec V.: Biochem. Pharmacol. 67, 1097 (2004).
20. Neidle S.: Nat. Prod. Rep. 18, 291 (2001).
21. Lown J.W.: Acc. Chem. Res. 15, 381 (1982).
22. McGowan G., Parsons S., Sadler P.J.: Inorg. Chem. 44, 7459 (2005).
23. Boccarelli A., Intini F.P., Sasanelli R., Sivo M.F., Coluccia M., Natile G.: J. Med. Chem. 49, 829 (2006).
24. Kasparkova J., Novakova O., Farrell N., Brabec V.: Biochemistry 42, 792 (2003).
25. Kasparkova J., Novakova O., Marini V., Najajreh Y., Gibson D., Perez J.M., Brabec V., J. Biol. Chem. 278, 47516 (2003).
26. Fortune J.M., Osheroff N.: Prog. Nucleic Res. Mol. Biol., 64, 221 (2000).
27. Champoux J.J.: Annu. Rev. Biochem., 70, 369 (2001).
28. Gruber B.M., Anuszewska E.L., Roman I., Goździk A., Priebe W., Fokt I.: Acta Pol. Pharm. Drug Res. 63, 15 (2006).